EP 1742914 A1 20070117 - CYCLOBUTENEDIONE GROUPS-CONTAINING COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE
Title (en)
CYCLOBUTENEDIONE GROUPS-CONTAINING COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE
Title (de)
CYCLOBUTENDIONGRUPPENHALTIGE VERBINDUNGEN ALS INHIBITOREN DER NS3-SERINPROTEASE DES HEPATITIS-C-VIRUS
Title (fr)
GROUPES CYCLOBUTENEDIONE CONTENANT DES COMPOSES SERVANT D'INHIBITEURS A LA SERINE PROTEASE NS3 DU VIRUS DE L'HEPATITE C
Publication
Application
Priority
- US 2005006083 W 20050224
- US 54842304 P 20040227
Abstract (en)
[origin: WO2005085197A1] The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
IPC 8 full level
C07D 209/52 (2006.01); A61K 31/403 (2006.01); A61K 31/407 (2006.01); A61P 31/12 (2006.01); C07D 491/04 (2006.01); C07K 5/08 (2006.01); C07K 7/02 (2006.01); C07D 209/00 (2006.01); C07D 307/00 (2006.01)
CPC (source: EP)
A61P 1/16 (2017.12); A61P 3/12 (2017.12); A61P 31/12 (2017.12); A61P 31/14 (2017.12); A61P 43/00 (2017.12); C07D 209/52 (2013.01); C07D 491/04 (2013.01)
Citation (search report)
See references of WO 2005085197A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR LV MK YU
DOCDB simple family (publication)
WO 2005085197 A1 20050915; CA 2557301 A1 20050915; CN 1946690 A 20070411; EP 1742914 A1 20070117; JP 2007525521 A 20070906
DOCDB simple family (application)
US 2005006083 W 20050224; CA 2557301 A 20050224; CN 200580012651 A 20050224; EP 05723791 A 20050224; JP 2007501006 A 20050224